Coexisting follicular and mantle cell lymphoma with each having an in situ component: A novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma

American Journal of Clinical Pathology

Volumn 133, Issue 4, 2010, Pages 584-591

  Roullet, Michele R ^a   Martinez, Daniel ^b   Ma, Lisa ^c   Fowler, Melissa Halpern ^d   McPhail, Ellen D ^e   Judkins, Alexander ^b   Arber, Daniel A ^c   Bagg, Adam ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Saint Vincent Health Center   (United States)

^e MAYO CLINIC   (United States)

Author keywords

Composite; Follicular; In situ; Lymphoma; Mantle cell

Indexed keywords

CYCLIN D1; PROTEIN BCL 2; LEUKOCYTE ANTIGEN;

AGED; ANAMNESIS; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MANTLE CELL LYMPHOMA; MEDICAL DOCUMENTATION; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECTUM CARCINOMA; SPLENECTOMY; FATALITY; GENETICS; METABOLISM; MULTIPLE CANCER; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN TUMOR;

AGED, 80 AND OVER; ANTIGENS, CD; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, FOLLICULAR; LYMPHOMA, MANTLE-CELL; NEOPLASMS, MULTIPLE PRIMARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLENECTOMY; SPLENIC NEOPLASMS;

EID: 77950512055     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP5RT4MRSDGKSX     Document Type: Article

References (31)

1. Kim H. Composite lymphoma and related disorders. Am J Clin Pathol. 1993;99:445-451.
2. Ioachim HM, Medeiros LJ, eds. Ioachim's Lymph Node Pathology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009.
3. Fend F, Quintanilla-Martinez L, Kumar S, et al. Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas: a molecular analysis using laser capture microdissection. Am J Pathol. 1999;154:1857-1866. (Pubitemid 29262869)
4. Tsang P, Pan L, Cesarman E, et al. A distinctive composite lymphoma consisting of clonally related mantle cell lymphoma and follicle center cell lymphoma. Hum Pathol. 1999;30:988-992. (Pubitemid 29380526)
5. Schmitz R, Renne C, Rosenquist R, et al. Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas. Leukemia. 2005;19:1452-1458. (Pubitemid 41136341)
6. Caleo A, Sanchez-Aguilera A, Rodriguez S, et al. Composite Hodgkin lymphoma and mantle cell lymphoma: two clonally unrelated tumors. Am J Surg Pathol. 2003;27:1577-1580. (Pubitemid 37486621)
7. Lefebvre C, Fabre B, Vettier C, et al. Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones. Hum Pathol. 2007;38:660-667. (Pubitemid 46420342)
8. Mokhtar NM. Review article composite lymphoma. J Egypt Natl Canc Inst. 2007;19:171-175.
9. Kaleem Z, McGuire MH, Caracioni AC, et al. Composite B-cell and T-cell non-Hodgkin lymphoma of the tibia. Am J Clin Pathol. 2005;123:215-221. (Pubitemid 40194082)
10. Campidelli C, Sabattini E, Piccioli M, et al. Simultaneous occurrence of peripheral T-cell lymphoma unspecified and B-cell small lymphocytic lymphoma: report of 2 cases. Hum Pathol. 2007;38:787-792. (Pubitemid 46560794)
11. Hayes SJ, Banerjee SS, Cook Y, et al. Composite mantle-cell lymphoma and classical Hodgkin lymphoma. Histopathology. 2006;48:621-623.
12. Tinguely M, Rosenquist R, Sundstrom C, et al. Analysis of a clonally related mantle cell and Hodgkin lymphoma indicates Epstein-Barr virus infection of a Hodgkin/Reed-Sternberg cell precursor in a germinal center. Am J Surg Pathol. 2003;27:1483-1488.
13. Aqel N, Barker F, Patel K, et al. In-situ mantle cell lymphoma: a report of two cases. Histopathology. 2008;52:256-260.
14. Looi A, Gascoyne RD, Chhanabhai M, et al. Mantle cell lymphoma in the ocular adnexal region. Ophthalmology. 2005;112:114-119.
15. Zamo A, Zanotti R, Lestani M, et al. Molecular characterization of composite mantle cell and follicular lymphoma. Virchows Arch. 2006;448:639-643.
16. Ilgenfritz RB, Le Tourneau A, Arborio M, et al. Composite mantle cell and follicular lymphoma: a case report. Hum Pathol. 2009;40:259-263.
17. Rodig SJ, Healey BM, Pinkus GS, et al. Mantle cell lymphoma arising within primary nodal marginal zone lymphoma: a unique presentation of two uncommon B-cell lymphoproliferative disorders. Cancer Genet Cytogenet. 2006;171:44-51.
18. Elmahy H, Hawley I, Beard J. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma: an unusual combination. Int J Lab Hematol. 2007;29:461-463.
19. Cachia AR, Diss TC, Isaacson PG. Composite mantle-cell lymphoma and plasmacytoma. Hum Pathol. 1997;28:1291-1295.
20. Wang HY, Karandikar N, Payne D, et al. A 3-way collision tumor of the upper respiratory tract: a composite of 2 immunophenotypically distinct mantle cell lymphomas and a plasmacytoma. Hum Pathol. 2008;39:781-787.
21. Korac P, Jones M, Dominis M, et al. Application of the FICTION technique for the simultaneous detection of immunophenotype and chromosomal abnormalities in routinely fixed, paraffin wax embedded bone marrow trephines. J Clin Pathol. 2005;58:1336-1338.
22. Mattsson G, Tan SY, Ferguson DJ, et al. Detection of genetic alterations by immunoFISH analysis of whole cells extracted from routine biopsy material. J Mol Diagn. 2007;9:479-489.
23. Morales AV, Arber DA, Seo K, et al. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates. Am J Dermatopathol. 2008;30:425-430.
24. Bassarova A, Tierens A, Lauritzsen GF, et al. Mantle cell lymphoma with partial involvement of the mantle zone: an early infiltration pattern of mantle cell lymphoma? Virchows Arch. 2008;453:407-411.
25. Nodit L, Bahler DW, Jacobs SA, et al. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol. 2003;34:1030-1034.
26. Orchard J, Garand R, Davis Z, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood. 2003;101:4975-4981.
27. Cong P, Raffeld M, Teruya-Feldstein J, et al. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood. 2002;99:3376-3382.
28. Sotomayor EA, Shah IM, Sanger WG, et al. In situ follicular lymphoma with a 14;18 translocation diagnosed by a multimodal approach. Exp Mol Pathol. 2007;83:254-258.
29. Schraders M, de Jong D, Kluin P, et al. Lack of bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation. J Pathol. 2005;205:329-335.
30. Howard MT, Dufresne S, Swerdlow SH, et al. Follicular lymphoma of the spleen: multiparameter analysis of 16 cases. Am J Clin Pathol. 2009;131:656-662.
31. Mollejo M, Rodriguez-Pinilla MS, Montes-Moreno S, et al. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases. Am J Surg Pathol. 2009;33:730-738.